Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01174953 · ClinicalTrials.gov registry record · NA
High Risk Prostate Cancer Prevention Study
A NA study, sponsored by University of Kansas.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01174953 is a NA study that has completed, run by University of Kansas. The registered enrollment target is 18 participants.
The verdict
NCT01174953, a NA study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to study the molecular effects of the chemopreventative agent, finasteride, in combination with dietary soy supplementation in patients at high risk for the development of prostate cancer. Also, the investigators intend to create a large database with health information from men who are at high risk of developing prostate cancer, along with serum and tissue samples from those patients who are willing to provide tissue and serum samples.
Interventions
- DRUG finasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01174953
The ClinicalTrials.gov registry entry for NCT01174953 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which finasteride is the first listed.
NCT01174953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01174953 about?
NCT01174953 is a clinical study titled "High Risk Prostate Cancer Prevention Study". The purpose of this study is to study the molecular effects of the chemopreventative agent, finasteride, in combination with dietary soy supplementation in patients at high risk for the development of prostate cancer. Also, the investigators intend to create a large database with health information ...
What is the current status of trial NCT01174953?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2010-07. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01174953?
The interventions under investigation include: finasteride (DRUG).
Who is sponsoring clinical trial NCT01174953?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.